Similarly, unique targets to epilepsy antagonizers involved homeostasis through hormonal balance (estrogen, steroid, corticosteroid, prolactin, insulin, progestogen, and thyroid), inhibition of cellular processes (protein synthesis, TNF production, DNA replication, DNA synthesis, RNA synthesis, dopamine uptake, and cell proliferation), and inhibition of proliferative and detoxifying enzymes activity. The gene discussed is PRL; the disease is epilepsy.